Energy for the AI Boom: Why the Nextera–Dominion Merger Could Reshape the Race to Power Data Centers
Key Takeaways: NextEra Energy and Dominion Energy recently announced a merger that would combine the biggest renewable energy developer in the country with the utility company powering the largest data...
What Inventors Should Know About AI-Assisted Inventions and Their Patentability
Key Takeaways: AI-assisted inventions are patentable under U.S. law, but only a person can be named as an inventor. The legal standard is the same regardless of whether AI was...
Litigation Update | May 2026
USPTO Director Signals Continued Pro-Patent Discretionary Denial Policy at the Patent Trial and Appeal Board Ted M. Cannon In a precedential decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc.,...
Trademark & Brand Protection Update | May 2026
Taylor Swift, Trademarks, and the Pursuit of a Federal Right of Publicity Dillon A. Koch & Jonathan Menkes Taylor Swift’s recent trademark filings for her voice and likeness point to a...
Aerospace Update | May 2026
Proposal for Streamlined U.S. Regulatory Approval for Novel Commercial Space Activities Tyler S. Cox Office of Space Commerce (“OSC”) has released a proposal for streamlining regulatory approval of novel commercial...
Life Science Update | May 2026
AI Risks With the Patent Office: What Life Science Companies Should Be Asking Now Robert J. Hilton, Ph.D. & Justin Culbertson, Ph.D. AI tools are reshaping patent preparation and prosecution,...
Applied Aerospace & Defense’s IPO Signals Continued Momentum in Defense Manufacturing
Key Takeaways: Ongoing geopolitical tensions are leading to an increase in defense-tech contractors filing for IPOs. Aerospace & defense companies looking to capitalize on this trend should consider strengthening their...
Access Plus Similarity Starts the Clock for Trade Secret Misappropriation Claims
Insulet Corp. v. EOFlow, Co. Ltd. Before Dyk, Prost, and Reyna. Appeal from the United States District Court for the District of Massachusetts. Summary: A trade secret misappropriation claim accrues...
Medtronic to Acquire Spr Therapeutics for $650 Million
Medtronic announced its plans to acquire SPR Therapeutics, a privately held medical device company that specializes in non-opioid, non-surgical, and minimally invasive solutions for acute and chronic pain. The transaction is valued at...
